{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(3)"],"submitter":["Glassman H"],"pubmed_abstract":["<h4>Background</h4>There are associated adverse effects with intravenous (IV) vancomycin, yet there is a paucity of published literature surveying the appropriateness of use. The objective of the study was to assess the appropriateness of IV vancomycin prescriptions at a Canadian acute care hospital.<h4>Methods</h4>A pilot, pragmatic antimicrobial stewardship initiative using prospective audit and feedback (PAF) was conducted on incident IV vancomycin prescriptions for 4 weeks in 2022. The primary outcome was the percentage of IV vancomycin prescriptions assessed as appropriate against institutional prescribing guidelines. The secondary outcomes were to evaluate factors affecting appropriateness and to determine the number and types of ASP recommendations where IV vancomycin was assessed a"],"journal":["Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada"],"pagination":["252-256"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12656756"],"repository":["biostudies-literature"],"pubmed_title":["Appropriateness of intravenous vancomycin prescribing in a Canadian acute care hospital."],"pmcid":["PMC12656756"],"pubmed_authors":["Glassman H","Stewart JJ","Ismail A","Smith SW","Chen JZ","Kabbani D","Lau C"],"additional_accession":[]},"is_claimable":false,"name":"Appropriateness of intravenous vancomycin prescribing in a Canadian acute care hospital.","description":"<h4>Background</h4>There are associated adverse effects with intravenous (IV) vancomycin, yet there is a paucity of published literature surveying the appropriateness of use. The objective of the study was to assess the appropriateness of IV vancomycin prescriptions at a Canadian acute care hospital.<h4>Methods</h4>A pilot, pragmatic antimicrobial stewardship initiative using prospective audit and feedback (PAF) was conducted on incident IV vancomycin prescriptions for 4 weeks in 2022. The primary outcome was the percentage of IV vancomycin prescriptions assessed as appropriate against institutional prescribing guidelines. The secondary outcomes were to evaluate factors affecting appropriateness and to determine the number and types of ASP recommendations where IV vancomycin was assessed a","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-05T17:54:55.231Z","creation":"2026-05-19T03:12:02.748Z"},"accession":"S-EPMC12656756","cross_references":{"pubmed":["41311614"],"doi":["10.3138/jammi-2024-0040"]}}